<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05051280</url>
  </required_header>
  <id_info>
    <org_study_id>CBCT-FIG-LAAO</org_study_id>
    <nct_id>NCT05051280</nct_id>
  </id_info>
  <brief_title>Left Atrial Appendage Occlusion Under Cone-beam Computed Tomography Fusion Image Guidance</brief_title>
  <official_title>Combination of Cone Beam Computed Tomography and Cardiac Computed Tomography Angiography: Left Atrial Appendage Occlusion Under Three-dimensional Computed Tomography Fusion Image Guidance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Left atrial appendage occlusion is being widely recommended as a treatment strategy for&#xD;
      patients with nonvalvular AF to prevent stroke, especially those who cannot tolerate&#xD;
      long-term oral anticoagulation or have other reasons for nonpharmacologic therapy. Currently,&#xD;
      there are a number of guidance for left atrial appendage occlusion, such as transesophageal&#xD;
      echocardiography, intracardiac echocardiogram, fluoroscopy, computed tomographic/computed&#xD;
      tomographic angiography and so on. Procedures such as atrial septal puncture, device size&#xD;
      selection and operational view are guided by different methods in various centers. Our center&#xD;
      has developed a new approach to guidance: Cone-beam CT and cardiac computed tomographic&#xD;
      angiography were combined by three-dimensional - three-dimensional image fusion in guiding&#xD;
      left atrial appendage occlusion.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible NVAF patients were recruited consecutively and received our LAAO workflow of local&#xD;
      anesthesia, intracardiac echocardiography-guided transseptal puncture, and 3DCTA-3DCBCTF&#xD;
      fusion-guided occluder implantation. The primary outcome was optimal occluder implantation&#xD;
      (successful implantation with no occluder recapture and replacement). Other outcomes were&#xD;
      procedure/fluoroscopic time, contrast agent consumption, radiation dose, and peri-procedure&#xD;
      complications. We compared our results with existing publications of LAAO guided by 3DCTA and&#xD;
      two-dimensional fluoroscopy (3DCTA-2DF) fusion images.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>rate of success at first device selected</measure>
    <time_frame>In surgery</time_frame>
    <description>successful occluder deployment and release with no being resized</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>CBCT guidance group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Left atrial appendage occlusion under cone-beam computed tomography fusion image guidance</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cone-beam computed tomography fusion image</intervention_name>
    <description>Left Atrial Appendage Occlusion Under Cone-beam Computed Tomography Fusion Image Guidance</description>
    <arm_group_label>CBCT guidance group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. An age of &gt;18 years;&#xD;
&#xD;
          2. A CHA2DS2-VASc score of ≥2;&#xD;
&#xD;
          3. Clinical conditions allowing TEE and sedation;&#xD;
&#xD;
          4. Left ventricular ejection fraction &gt;30%;&#xD;
&#xD;
          5. And at least one of the following indications: (a) HAS-BLED score of ≥3; (b)&#xD;
             intolerance to long-term OAC, and (c) stroke, transient ischemic attack, or&#xD;
             thromboembolism even under oral anticoagulation treatment;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. A glomerular filtration rate of &lt;50 mL/min/1.73 m2;&#xD;
&#xD;
          2. The presence of a thrombus in the LA and LAA;&#xD;
&#xD;
          3. Acute myocardial infarction or unstable angina, decompensated heart failure (New York&#xD;
             Heart Association functional class III-IV), or heart transplantation;&#xD;
&#xD;
          4. Stroke or transient ischemic attack within 30 days;&#xD;
&#xD;
          5. Very poor peripheral vessel access not allowing device delivery;&#xD;
&#xD;
          6. Moderate or massive pericardial effusion.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>JUN PU, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Shanghai Jiao Tong University, School of Medicine, Affiliated Ren Ji Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>JUN PU, Doctor</last_name>
    <phone>13817577592</phone>
    <email>Pujun310@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Jiaotong University School of Medcine, Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JUN PU, Doctor</last_name>
      <phone>13817577592</phone>
      <email>Pujun310@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 12, 2021</study_first_submitted>
  <study_first_submitted_qc>September 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2021</study_first_posted>
  <last_update_submitted>September 12, 2021</last_update_submitted>
  <last_update_submitted_qc>September 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

